North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Breath Testing, Small Intestine Aspirate and Fluid Culture Test, Blood Test, and Others) and Type (Hydrogen-predominant SIBO, Methane-predominant SIBO, and Recurrent SIBO)

Market Introduction

North America market has been segmented into the US, Canada, and Mexico. The US dominated the North America market in 2020. The market's growth is primarily attributed to the increasing prevalence of conditions such as immunodeficiency syndromes and pancreatic exocrine insufficiency amongst others. Growing prevalence of risk factors associated with the SIBO are also expected to drive the prevalence of the condition, which will eventually offer favorable environment for growth of US small intestinal bacterial overgrowth diagnostics market by 2027. For instance, according to a study published by group of researchers at Northwell Health System, Division of Gastroenterology, New York in 2017, obesity is one of the prominent causes and risk factors to drive the bacterial overgrowth in small intestine. Small intestinal bacterial overgrowth (SIBO) has been incorporated with anatomical and motility-related abnormalities. Mainly, obesity has been proposed to change small bowel motility, leading to SIBO. As a result, SIBO was more frequent amongst obese patients vs. non-obese patients (88.9% vs. 42.9%). Obese vs. non-obese patients presented notable differences in microbiome diversity in rectal samples. Obesity was connected with increased odds of developing SIBO. Therefore, rising prevalence of obesity will ultimately offer a lucrative opportunity for growth of the market. Growing prevalence of IBS and SIBO and increasing advantages of breath test are the major factor driving the growth of the North America small intestinal bacterial overgrowth (SIBO) diagnostics market.

In case of COVID-19, North America is highly affected specially the US. Industrial sectors in the countries such as the US and Canada has experienced disruption in various industries, including healthcare. However, the need for diagnosis and treatment for the COVID positive patients has carried on business cycles in the medical sector. In addition, the rising demand for personal protective equipment has tried to stabilize the business cycle for the healthcare industry. According to an article issued by Harvard Medical School, infectious viral particles can live in the air for three hours. As a result, it can cause patient scheduling obstructions and put others at risk for contracting the virus. For healthcare providers demanding to test for GI-related problems offered by patients, a substitute for in-office breath testing must be granted due to the potential spread of COVID-19 through aerosolization. Unfortunately, the possible aerosolization spread of COVID-19 makes breath testing in-office comparatively unsafe and has been in a bit of a dilemma in the clinic during this pandemic. The small intestinal bacterial overgrowth diagnostics market also witnessed major decline due to lowered number of diagnostic procedures. Substantial focus on management of COVID had direct impact on diagnostics of abdominal conditions such as irritable bowel syndrome, SIBO, and lactose intolerance. In addition, patients showed reluctance for breath and blood tests due to fear of COVID infection. These factors consequently led to adverse impact on North America small intestinal bacterial overgrowth market during the pandemic period. However, the market is expected to witness considerable growth post-pandemic. Certain factors such as rise in prevalence of SIBO and IBS are estimated to show positive impact on market growth.

Get more information on this report :

Market Overview and Dynamics

The North America small intestinal bacterial overgrowth (SIBO) diagnostics market is expected to grow from US$ 53,452.06 thousand in 2021 to US$ 73,794.03 thousand by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028. There has been a constant development in SIBO diagnostics. The currently used breath test has low sensitivity and specificity. Therefore, the additional validation studies are undergoing to define standard protocols. The growing technological developments in the field of medical devices have offered various innovative products to diagnose several complex human health conditions. Thus, to diagnose SIBO, an innovative orally ingested capsule technology is in the developmental process. It is designed in a way to measure in vivo hydrogen and carbon-di-oxide after ingestion of a carbohydrate meal and provide a technologically updated alternative to the current breath hydrogen test. It is expected that the capsule technology will help in diagnosing samples of small bowel bacteria. Thus, the introduction of capsule technology is likely to emerge in the coming future and contribute to direct and accurate evaluation of SIBO and offer vital growth opportunities for the North America market’s growth.

Key Market Segments

In terms of diagnosis, the breath testing segment accounted for the largest share of the North America small intestinal bacterial overgrowth (SIBO) diagnostics market in 2020. In terms of type, the hydrogen-predominant SIBO segment held a larger market share of the North America small intestinal bacterial overgrowth (SIBO) diagnostics market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the North America small intestinal bacterial overgrowth (SIBO) diagnostics market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Aerodiagnostics, LLC.; Commonwealth Diagnostics International; DirectLabs, LLC.; Genova Diagnostics; Health Associates Medical Group; Metabolic Solutions, Inc.; Pivotal Diagnostics; SIBO Diagnostics; SIBOTest; and Vibrant Wellness.

Reasons to buy report

To understand the North America small intestinal bacterial overgrowth (SIBO) diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for North America small intestinal bacterial overgrowth (SIBO) diagnostics market
Efficiently plan M&A and partnership deals in North America small intestinal bacterial overgrowth (SIBO) diagnostics market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America small intestinal bacterial overgrowth (SIBO) diagnostics market
Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segmentation

North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Diagonisis

Breath Testing
- 14C Xylose Breath Test
- Hydrogen Breath Tests
- 14C Glycocholic Acid Breath Test
- Malabsorption Tests
Small Intestine Aspirate and Fluid Culture Test
Blood Test
Others

North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Type

Hydrogen-predominant SIBO
Methane-predominant SIBO
Recurrent SIBO

North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market , By Country

US
Canada
Mexico

North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market - Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Diagnosis

1.3.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Type

1.3.3 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Expert Opinion

5. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Growing Prevalence of IBS and SIBO

5.1.2 Increasing Advantages of Breath Test

5.2 Key Market Restraints

5.2.1 Limitations of Diagnosis

5.3 Key Market Opportunities

5.3.1 Escalation in the Usage of Capsule Technology

5.4 Future Trends

5.4.1 Rise of NGS Technologies to Diagnose SIBO

5.5 Impact Analysis

6. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – North America Analysis

6.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue Forecast and Analysis

7. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis– by Diagnosis

7.1 Overview

7.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

7.3 Breath Testing

7.3.1 Overview

7.3.2 Breath Testing: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.3.3C Xylose Breath Test

7.3.3.1 Overview

7.3.3.2C Xylose Breath Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.3.4 Hydrogen and Methane Breath Tests

7.3.4.1 Overview

7.3.4.2 Hydrogen and Methane Breath Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.3.5C Glycocholic Acid Breath

7.3.5.1 Overview

7.3.5.2C Glycocholic Acid Breath: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.3.6 Malabsorption Tests

7.3.6.1 Overview

7.3.6.2 Malabsorption Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.4 Small Intestine Aspirate and Fluid Culture Test

7.4.1 Overview

7.4.2 Small Intestine Aspirate and Fluid Culture Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.5 Blood Test

7.5.1 Overview

7.5.2 Blood Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

7.6 Others

7.6.1 Overview

7.6.2 Others: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

8. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis– by Type

8.1 Overview

8.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type 2020 & 2028 (%)

8.3 Hydrogen-predominant SIBO

8.3.1 Overview

8.3.2 Hydrogen-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

8.4 Methane-predominant SIBO

8.4.1 Overview

8.4.2 Methane-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

8.5 Recurrent SIBO

8.5.1 Overview

8.5.2 Recurrent SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

9. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Country Analysis

9.1 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market

9.1.1 Overview

9.1.2 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)

9.1.3 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

9.1.3.1 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

9.1.3.2 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)

9.1.3.2.1 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)

9.1.3.3 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)

9.1.4 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

9.1.4.1 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

9.1.4.2 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)

9.1.4.2.1 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)

9.1.4.3 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)

9.1.5 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

9.1.5.1 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

9.1.5.2 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)

9.1.5.2.1 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)

9.1.5.3 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)

10. Impact of COVID-19 Pandemic on North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Genova Diagnostics

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 SIBO Diagnostics

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Commonwealth Diagnostics International

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Aerodiagnostics, LLC.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 SIBOTest

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Metabolic Solutions, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Pivotal Diagnostics

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 DirectLabs, LLC.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Vibrant Wellness

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Health Associates Medical Group

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Table 2. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)

Table 3. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)

Table 4. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 5. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)

Table 6. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)

Table 7. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 8. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)

Table 9. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)

Table 10. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 11. Organic Developments Done by Companies

Table 12. Inorganic Developments Done by Companies

Table 13. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segmentation

Figure 2. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Country

Figure 3. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Overview

Figure 4. Breath Test Segment Held Largest Share of Market by Diagnosis

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America: PEST Analysis

Figure 7. Expert Opinion

Figure 8. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue Forecast and Analysis

Figure 10. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

Figure 11. North America Breath Testing: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 12. North America 14C Xylose Breath Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 13. North America Hydrogen and Methane Breath Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 14. North America 14C Glycocholic Acid Breath: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 15. North America Malabsorption Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 16. North America Small Intestine Aspirate and Fluid Culture Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 17. North America Blood Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 18. North America Others: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 19. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type 2020 & 2028 (%)

Figure 20. North America Hydrogen-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 21. North America Methane-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 22. North America Recurrent SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 23. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)

Figure 24. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 25. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 26. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 27. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 28. Impact of COVID-19 Pandemic in North American Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America small intestinal bacterial overgrowth (SIBO) diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America small intestinal bacterial overgrowth (SIBO) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the small intestinal bacterial overgrowth (SIBO) diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample